{"action":"transfer","city":"Solna","companyRegistrationNumber":"5593436495","conformityFlag":"CONFORMING","country":"SE","createdAt":"2021-10-30T02:00:00+02:00","entityCategory":"GENERAL","entityStatus":"ACTIVE","entitySubCategory":null,"expirationReason":null,"expiredAt":null,"family":{"children":[],"childrenTotal":0,"exceptions":[{"category":"DIRECT_ACCOUNTING_CONSOLIDATION_PARENT","reasons":["NATURAL_PERSONS"],"references":[]},{"category":"ULTIMATE_ACCOUNTING_CONSOLIDATION_PARENT","reasons":["NATURAL_PERSONS"],"references":[]}],"parents":[]},"headquartersAddress":"Nanna Svartz Väg 4","headquartersCity":"Solna","headquartersCountry":"SE","headquartersPostalCode":"171 65","headquartersRegion":"SE-AB","lastUpdatedAt":"2025-12-09T11:22:00Z","legalAddress":"Nanna Svartz Väg 4","legalFormAbbreviation":"AB","legalFormCode":"XJHM","legalFormName":"Aktiebolag","legalJurisdiction":"SE","legalName":"Phase2Phase Biopharma Ventures AB","lei":"549300K7DS5MPFEMQT61","managingLou":"549300O897ZC5H7CY412","managingLouName":"NordLEI","managingLouWebsite":"https://nordlei.org","nextRenewalAt":"2027-01-28T10:18:00Z","otherLegalForm":null,"postalCode":"171 65","region":"SE-AB","registeredAt":"2022-01-28T21:30:00Z","registrationAuthorityId":"RA000544","registrationAuthorityName":"Companies Register","registrationAuthorityWebsite":"https://www.bolagsverket.se","registrationNumber":"559343-6495","registrationNumberFormatted":"559343-6495","registrationStatus":"ISSUED","served":true,"successorLeis":[],"validationAuthorityEntityId":"559343-6495","validationAuthorityId":"RA000544","validationAuthorityName":"Companies Register","validationSources":"FULLY_CORROBORATED"}